Skip to content

Rabeprazole Impurity 6

Rabeprazole Impurity 6

Product Description
CAT No.
ALN-R006034
CAS No.
NA
Mol. F.
C36H39N6O4S
Mol. Wt.
651.8
Stock
Please Inquire
RFQ
Chemical Name : 1-(1H-benzo[d]imidazol-2-yl)-4-(3-methoxypropoxy)-2-(((2-(3-methoxypropoxy)-1-methylbenzo[4′,5′]imidazo[2′,1′:2,3]imidazo[1,5-a]pyridin-12-yl)thio)methyl)-3-methylpyridin-1-ium
Smiles : COCCCOC(C(C)=C1CSC2=C3N(C=CC(OCCCOC)=C3C)C4=NC5=C(C=CC=C5)N24)=CC=[N+]1C6=NC7=CC=CC=C7N6
Inchi : InChI=1S/C14H11N3O3/c1-8-11(6-7-15-12(8)13(18)19)20-14-16-9-4-2-3-5-10(9)17-14/h2-7H,1H3,(H,16,17)(H,18,19)

Identification, isolation and characterization of new impurity in rabeprazole sodium

P. SreenivasaRao, Uttam KumarRay, P. BadarinadhGupta, D.V.N. SrinivasaRao, AminulIslam, PradeepRajput, K.MukkantinJournal of Pharmaceutical and Biomedical Analysis Volume 52, Issue 4, 1 August 2010, Pages 620-624

Development and validation of a stability indicating hplc method for the estimation of rabeprazole impurities in pharmaceutical dosage forms by design of experiments

T.v. raghava raju, s.raja kumar1, i.mrutyunjaya rao, n.someswara rao – Asian J Pharm Clin Res, Vol 6, Suppl4, 2013, 43-51

Identification and characterization of stressed degradation products of rabeprazole using LC-ESI/MS/MS and 1H-NMR experiments: in vitro toxicity evaluation of major degradation products

Murali Mohan Bhandi,a\xa0\xa0 Roshan M. Borkar,a\xa0\xa0 G. Shankar,a\xa0\xa0 Snehal Raut,b\xa0\xa0 Narayana Nageshc\xa0 and\xa0 R. Srinivas

Request For Quotation